Literature DB >> 29281820

Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.

Josh Lewis Stern1, Richard D Paucek1, Franklin W Huang2, Mahmoud Ghandi3, Ronald Nwumeh1, James C Costello4, Thomas R Cech5.   

Abstract

A mutation in the promoter of the Telomerase Reverse Transcriptase (TERT) gene is the most frequent noncoding mutation in cancer. The mutation drives unusual monoallelic expression of TERT, allowing immortalization. Here, we find that DNA methylation of the TERT CpG island (CGI) is also allele-specific in multiple cancers. The expressed allele is hypomethylated, which is opposite to cancers without TERT promoter mutations. The continued presence of Polycomb repressive complex 2 (PRC2) on the inactive allele suggests that histone marks of repressed chromatin may be causally linked to high DNA methylation. Consistent with this hypothesis, TERT promoter DNA containing 5-methyl-CpG has much increased affinity for PRC2 in vitro. Thus, CpG methylation and histone marks appear to collaborate to maintain the two TERT alleles in different epigenetic states in TERT promoter mutant cancers. Finally, in several cancers, DNA methylation levels at the TERT CGI correlate with altered patient survival.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-methylcytosine; CpG island; PRC2; Polycomb repressive complex 2; TERT promoter; allele-specific; cancer; monoallelic; telomerase

Mesh:

Substances:

Year:  2017        PMID: 29281820      PMCID: PMC5747321          DOI: 10.1016/j.celrep.2017.12.001

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  42 in total

Review 1.  Linking DNA methylation and histone modification: patterns and paradigms.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

Review 2.  Marked for death: targeting epigenetic changes in cancer.

Authors:  Sophia Xiao Pfister; Alan Ashworth
Journal:  Nat Rev Drug Discov       Date:  2017-03-10       Impact factor: 84.694

3.  RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.

Authors:  John J Gildea; M Jabed Seraj; Gary Oxford; Michael A Harding; Garret M Hampton; Christopher A Moskaluk; Henry F Frierson; Mark R Conaway; Dan Theodorescu
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

4.  Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.

Authors:  Pedro Castelo-Branco; Sanaa Choufani; Stephen Mack; Denis Gallagher; Cindy Zhang; Tatiana Lipman; Nataliya Zhukova; Erin J Walker; Dianna Martin; Diana Merino; Jonathan D Wasserman; Cynthia Elizabeth; Noa Alon; Libo Zhang; Volker Hovestadt; Marcel Kool; David T W Jones; Gelareh Zadeh; Sidney Croul; Cynthia Hawkins; Johann Hitzler; Jean C Y Wang; Sylvain Baruchel; Peter B Dirks; David Malkin; Stefan Pfister; Michael D Taylor; Rosanna Weksberg; Uri Tabori
Journal:  Lancet Oncol       Date:  2013-04-16       Impact factor: 41.316

5.  UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9.

Authors:  Xiaoli Liu; Qinqin Gao; Pishun Li; Qian Zhao; Jiqin Zhang; Jiwen Li; Haruhiko Koseki; Jiemin Wong
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.

Authors:  Isabelle Guilleret; Jean Benhattar
Journal:  Biochem Biophys Res Commun       Date:  2004-12-17       Impact factor: 3.575

7.  An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment.

Authors:  Magnus D Lynch; Andrew J H Smith; Marco De Gobbi; Maria Flenley; Jim R Hughes; Douglas Vernimmen; Helena Ayyub; Jacqueline A Sharpe; Jacqueline A Sloane-Stanley; Linda Sutherland; Stephen Meek; Tom Burdon; Richard J Gibbons; David Garrick; Douglas R Higgs
Journal:  EMBO J       Date:  2011-11-04       Impact factor: 11.598

8.  TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours.

Authors:  Janet C Lindsey; Ed C Schwalbe; Sandeep Potluri; Simon Bailey; Daniel Williamson; Steven C Clifford
Journal:  Acta Neuropathol       Date:  2013-12-12       Impact factor: 17.088

9.  Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.

Authors:  Josh Lewis Stern; Dan Theodorescu; Bert Vogelstein; Nickolas Papadopoulos; Thomas R Cech
Journal:  Genes Dev       Date:  2015-10-29       Impact factor: 11.361

10.  Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi.

Authors:  Yiping Fan; Seungjae Lee; Gang Wu; John Easton; Donald Yergeau; Reinhard Dummer; Peter Vogel; John M Kirkwood; Raymond L Barnhill; Alberto Pappo; Armita Bahrami
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

View more
  35 in total

1.  Analysis of longissimus muscle quality characteristics and associations with DNA methylation status in cattle.

Authors:  Zhi Chen; Shuangfeng Chu; Xin Xu; Jingyi Jiang; Wenqiang Wang; Hongliang Shen; Mingxun Li; Huimin Zhang; Yongjiang Mao; Zhangping Yang
Journal:  Genes Genomics       Date:  2019-06-29       Impact factor: 1.839

2.  Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.

Authors:  Pablo Tamayo; Thomas R Cech; Franklin W Huang; Josh Lewis Stern; Grace Hibshman; Kevin Hu; Sarah E Ferrara; James C Costello; William Kim
Journal:  Mol Cancer Res       Date:  2020-04-10       Impact factor: 5.852

3.  Single-cell imaging reveals unexpected heterogeneity of telomerase reverse transcriptase expression across human cancer cell lines.

Authors:  Teisha J Rowland; Gabrijela Dumbović; Evan P Hass; John L Rinn; Thomas R Cech
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

4.  ATAC-Me Captures Prolonged DNA Methylation of Dynamic Chromatin Accessibility Loci during Cell Fate Transitions.

Authors:  Kelly R Barnett; Benjamin E Decato; Timothy J Scott; Tyler J Hansen; Bob Chen; Jonathan Attalla; Andrew D Smith; Emily Hodges
Journal:  Mol Cell       Date:  2020-01-29       Impact factor: 17.970

5.  Telomere dysfunction cooperates with epigenetic alterations to impair murine embryonic stem cell fate commitment.

Authors:  Aditi Qamra; Tsz Wai Chu; Mélanie Criqui; Monika Sharma; Julissa Tsao; Danielle A Henry; Dalia Barsyte-Lovejoy; Cheryl H Arrowsmith; Neil Winegarden; Mathieu Lupien; Lea Harrington
Journal:  Elife       Date:  2020-04-16       Impact factor: 8.140

6.  DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.

Authors:  Donghyun D Lee; Ricardo Leão; Martin Komosa; Marco Gallo; Cindy H Zhang; Tatiana Lipman; Marc Remke; Abolfazl Heidari; Nuno Miguel Nunes; Joana D Apolónio; Aryeh J Price; Ramon Andrade De Mello; João S Dias; David Huntsman; Thomas Hermanns; Peter J Wild; Robert Vanner; Gelareh Zadeh; Jason Karamchandani; Sunit Das; Michael D Taylor; Cynthia E Hawkins; Jonathan D Wasserman; Arnaldo Figueiredo; Robert J Hamilton; Mark D Minden; Khalida Wani; Bill Diplas; Hai Yan; Kenneth Aldape; Mohammad R Akbari; Arnavaz Danesh; Trevor J Pugh; Peter B Dirks; Pedro Castelo-Branco; Uri Tabori
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

7.  Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.

Authors:  Brittany A McKelvey; Timothy Gilpatrick; Yongchun Wang; Winston Timp; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2020-05-04       Impact factor: 6.568

Review 8.  Non-duplex G-Quadruplex Structures Emerge as Mediators of Epigenetic Modifications.

Authors:  Ananda Kishore Mukherjee; Shalu Sharma; Shantanu Chowdhury
Journal:  Trends Genet       Date:  2018-12-04       Impact factor: 11.639

9.  Allele-specific DNA methylation maps in monozygotic twins discordant for psychiatric disorders reveal that disease-associated switching at the EIPR1 regulatory loci modulates neural function.

Authors:  Qiyang Li; Zhongju Wang; Lu Zong; Linyan Ye; Junping Ye; Haiyan Ou; Tingyun Jiang; Bo Guo; Qiong Yang; Wenquan Liang; Jian Zhang; Yong Long; Xianzhen Zheng; Yu Hou; Fengchun Wu; Lin Zhou; Shufen Li; Xingbing Huang; Cunyou Zhao
Journal:  Mol Psychiatry       Date:  2021-05-07       Impact factor: 15.992

Review 10.  Not just a writer: PRC2 as a chromatin reader.

Authors:  Michael Uckelmann; Chen Davidovich
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.